Objectives:
The major cause of morbidity and mortality in Cystic Fibrosis is gradual deterioration of pulmonary function. This has been attributed to an excessive inflammatory response to chronic infection. The release of , from bronchial epithelial cells in particular, and the subsequent influx of neutrophils into the lungs play a large part in this process. Lowering IL-8 production, by modulating microRNAs (miRNAs), could have therapeutic benefit. miRNAs are noncoding RNAs that regulate gene transcription by degrading or preventing translation of mRNA. Here we investigate miRNAs that regulate IL-8 gene expression. Methods and Results: A search for miRNAs that target IL-8 was performed in silico (TargetScan, microRNA, PITA and Microcosm Targets) and a shortlist of possible miRNA candidates was created (n = 15). In parallel IL-8 mRNA-miRNA complexes were isolated from human 16HBE140 − bronchial epithelial cells using custom designed biotinylated DNA oligonucleotides complementary to exposed sequences in the IL-8 mRNA. IL-8 mRNA, but not other transcripts, was isolated with its cognate miRNAs bound. Conclusions: Profiling and validation of these IL-8 targeting miRNAs will identify miRNAs that regulate IL-8 and represent new therapeutic targets for CF. Background: Cystic Fibrosis (CF) is characterised by chronic lung inflammation. In CF, glucocorticoids (GC) are a widely used therapeutic tool. However, their efficiency, and the benefit/risk ratio are still discussed. In plasma, 90% of GC is bound to the chaperone protein corticosteroid-binding globulin (CBG) produced by the liver. Recent works enlightened the fact that, more than a simple carrier protein, CBG could also address GC specifically to the inflammation site, thereby modulating the response to GC in an inflammatory context. We show that GC have no effects on CBG expression in hepatic cell lines, but increases CBG transcripts in the lung cell lines. Surprisingly, we observe no CBG up-regulation in the blood of CF patients. Discussion: Comparative results from hepatic and lung cell lines enlighten a cellspecific regulation of CBG. Moreover, the transcript CBG up-regulation observed in CF patients is not correlated to CBG plasma levels. We hypothesise that such lack of increase in plasmatic CBG could participate to chronic lung inflammation in CF.
